| Item Type | Name |
|
Academic Article
|
Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
|
|
Academic Article
|
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A.
|
|
Academic Article
|
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
|
|
Academic Article
|
Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.
|
|
Academic Article
|
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
|
|
Academic Article
|
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
|
|
Academic Article
|
Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.
|
|
Academic Article
|
Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
|
|
Academic Article
|
The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
|
|
Academic Article
|
Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation.
|
|
Academic Article
|
HIV-1 Vpr: G2 cell cycle arrest, macrophages and nuclear transport.
|
|
Academic Article
|
Specific incorporation of heat shock protein 70 family members into primate lentiviral virions.
|
|
Academic Article
|
Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.
|
|
Academic Article
|
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
|
|
Academic Article
|
Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.
|
|
Academic Article
|
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
|
|
Academic Article
|
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
|
|
Academic Article
|
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.
|
|
Academic Article
|
Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
|
|
Academic Article
|
Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.
|
|
Academic Article
|
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.
|
|
Academic Article
|
Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.
|
|
Academic Article
|
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5a.
|
|
Academic Article
|
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
|
|
Academic Article
|
Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection.
|
|
Academic Article
|
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.
|
|
Academic Article
|
ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.
|
|
Academic Article
|
Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner.
|
|
Academic Article
|
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
|
|
Academic Article
|
Cyclophilin, TRIM5, and innate immunity to HIV-1.
|
|
Academic Article
|
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.
|
|
Academic Article
|
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
|
|
Academic Article
|
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
|
|
Academic Article
|
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
|
|
Academic Article
|
Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.
|
|
Academic Article
|
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
|
|
Academic Article
|
Specific incorporation of cyclophilin A into HIV-1 virions.
|
|
Academic Article
|
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
|
|
Academic Article
|
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
|
|
Academic Article
|
Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.
|
|
Academic Article
|
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
|
|
Concept
|
rev Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
Human Immunodeficiency Virus Proteins
|
|
Concept
|
Acquired Immunodeficiency Syndrome
|
|
Concept
|
vpr Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
Simian Immunodeficiency Virus
|
|
Concept
|
gag Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
nef Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
env Gene Products, Human Immunodeficiency Virus
|
|
Concept
|
vif Gene Products, Human Immunodeficiency Virus
|
|
Academic Article
|
Overcoming current limitations in humanized mouse research.
|
|
Academic Article
|
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.
|
|
Academic Article
|
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
|
|
Academic Article
|
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
|
|
Academic Article
|
Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex.
|
|
Academic Article
|
Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines.
|